Persistence of lysergic acid diethylamide in the plasma of human subjects

@article{Aghajanian1964PersistenceOL,
  title={Persistence of lysergic acid diethylamide in the plasma of human subjects},
  author={George K. Aghajanian and Oscar H. L. Bing},
  journal={Clinical Pharmacology \& Therapeutics},
  year={1964},
  volume={5}
}
Two micrograms per kilogram of LSD‐25 was administered intravenously to five normal human subjects. The concentration of drug in plasma was determined serially over the subsequent 8 hours. LSD‐25 was found to be present in human plasma in relatively large quantities during the period of peak effect. The half‐life of LSD‐25 in human plasma was calculated to be 175 minutes. 

Topics from this paper

Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry.
TLDR
The method was used to determine pharmacokinetic parameters for LSD after oral administration (1 microgram/kg) to a male volunteer and the apparent plasma half-life was determined to be 5.1 h.
The determination of LSD in human plasma following oral administration.
TLDR
This technique has been used for the assay of LSD in plasma following the oral administration of the drug at a dose of approximately 2 μg per kg body weight.
The fate of LSD in the body: forensic considerations.
TLDR
The metabolism of LSD has been studied by analysing plasma and urine samples from Rhesus monkeys treated with radioactively labelled LSD, which showed seven peaks of radioactivity which cross-reacted in the RIA procedure.
Correlation of performance test scores with “tissue concentration” of lysergic acid diethylamide in human subiects
TLDR
Performance scores on arithmetic tests were shown to be highly linearly correlated with the concentration in the “tissue” (outer) compartment, and the estimated half‐life for loss of LSD‐25 from the plasma compartment, based on the model, was 103 minutes compared with a half-life of 180 minutes calculated directly from plasma concentrations.
Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids.
TLDR
Recent reported methods based on gas and liquid chromatography, combined with single- and multiple-stage mass spectral analysis, now permit accurate detection and quantitation of LSD at sub-nanogram/milliliter concentrations.
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
TLDR
The acute subjective and sympathomimetic responses to lysergic acid diethylamide lasted up to 12 hours and were closely associated with the concentrations in plasma over time and exhibited no acute tolerance.
Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide
TLDR
Glycinexylidide is a metabolite of lidocaine that is frequently present in µg/ml concentrations in the plasma of patients treated with lidocane infusions for 24 hr or more, and GX adversely affects the mental performance of normal subjects at plasma concentrations comparable to those found in patients.
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
TLDR
The present pharmacokinetic data are important for the evaluation of clinical study findings and the interpretation of LSD intoxication, with moderate counterclockwise hysteresis.
Body fluid levels of lysergide (LSD).
TLDR
Results from 20 cases in which LSD was determined in body fluids by radioimmunoassay are summarized and the validity of methods used for LSD analysis is discussed.
Lysergic Acid Diethylamide Toxicity
TLDR
D-lysergic acid diethylamide, or LSD, is a compound of the lysergamide class known for its powerful psychedelic effects on humans, and remains as the most researched hallucinogen.
...
1
2
3
4
5
...

References

SHOWING 1-8 OF 8 REFERENCES
THE DISTRIBUTION AND METABOLISM OF LYSERGIC ACID DIETHYLAMIDE
TLDR
This first of several articles on the narcotic drug, Axelrod detailed the subcellular processes involved in the transformation of LSD, determined the order of concentrations of the drug in various tissues, and determined that it was almost completely metabolized by the body.
A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
  • H. Osmond
  • Medicine
    Annals of the New York Academy of Sciences
  • 1957
TLDR
The field of inquiry is limited by a definition that will prevent workers in this field from being overwhelmed with an inconveniently large poition of the pharmacopoeia, and this rough and ready guide excludes morphine, cocaine, atropine, and their derivatives.
Mescaline, LSD, psilocybin, and personality change.
... our normal waking consciousness ... is but one special type of consciousness, whilst all about it, parted from it by the filmiest of screens, there lie potential forms of consciousness entirely
The distribution and metabolism of lysergic acid diethylamide, Ann
  • New York Acad Sc
  • 1957
Distribution and fate of C " labeled lysergic acid diethylamide (LSD-25) in the animal body, Experientia
  • 1955
Distribution and fate of C14_ labeled lysergic acid diethylamide (LSD-25) in the animal
  • body, Experientia
  • 1955